LONDON, March 21, 2018 -- According to this latest publication from Meticulous Research™, NGS services market to reach USD 2,921.4 million by 2023, growing at a CAGR of 20.1% during the forecast period of 2018 to 2023. “Plummeting cost of sequencing, growing need of skilled professionals for efficient NGS sample preparation and analysis, technological advancements, increase in genome mapping programs, and high cost of sequencing infrastructure are the major factors driving the growth of NGS services market”, mentions Meticulous Research™.
The report also notes that, “growing application of NGS technology in cancer and agrigenomics research for the analysis of complex sequencing data and rising demand for personalized medicine provides significant opportunities to NGS service providers.”
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/?cp_id=3875
Geographically, North America dominated the global NGS services market in 2017, mainly due to the increasing burden of chronic and infectious diseases, growing R&D expenditure, various government initiatives, and the presence of many services providers in this region.
The key players in the global NGS services market are Illumina, Inc., Qiagen N.V., PerkinElmer, Inc., Eurofins Scientific SE, GATC Biotech AG, Macrogen, Inc., Genotypic Technology Pvt. Ltd., GENEWIZ, Inc., Beijing Genomics Institute, SciGenom Labs Pvt. Ltd., MedGenome, DNA Link, Inc., Otogenetics Corporation, Novogene Corporation, LGC Limited, CD Genomics, and SeqLL, LLC.
Full News: https://www.meticulousresearch.com/next-generation-sequencing-ngs-services-market-2023/
Scope of the Report:
Market by Service Type:
- Targeted Sequencing
- RNA Sequencing
- Exome Sequencing
- De Novo Sequencing
- ChIP-Sequencing
- Whole Genome Sequencing
- Methyl Sequencing
- Other Services
Market by Technology:
- Sequencing by Synthesis (SBS)
- Ion Semiconductor Sequencing (IOS)
- Single Molecule Real Time Sequencing (SMRT)
- Nanopore Sequencing
- True Single Molecule Sequencing (tSMS)
Market by Application:
- Diagnostics
- Drug Discovery
- Biomarker Discovery
- Agriculture & Animal Research
- Other Applications
Market by End User:
- Academic & Research Institutes
- Pharmaceuticals & Biotechnology Industry
- Hospitals & Clinics
- Other End Users
Market by Geography:
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Browse in-depth report here: https://www.meticulousresearch.com/product/next-generation-sequencing-ngs-services-market/
Contact Info:
Viren Shrivastava
Email: [email protected]
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 



